Seminars in Radiation Oncology

Papers
(The TQCC of Seminars in Radiation Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer40
Biology of Radiation-Induced Lung Injury32
Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer29
The Radiobiology of Radiopharmaceuticals24
Biology of HPV Mediated Carcinogenesis and Tumor Progression23
Epidemiology of HPV Related Malignancies23
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies22
The Role of Theranostics in Prostate Cancer21
Automated Radiation Treatment Planning for Cervical Cancer20
Regulatory Aspects of the Use of Artificial Intelligence Medical Software17
Quality Assurance for AI-Based Applications in Radiation Therapy16
Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy16
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology16
Automated Tumor Segmentation in Radiotherapy14
Meeting the Global Need for Radiation Therapy in Cervical Cancer—An Overview14
Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies14
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations13
Radiopharmaceuticals for Neuroendocrine Tumors13
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients12
Radiopharmaceutical Chemistry and Drug Development—What's Changed?12
Chromosome Missegregation as a Modulator of Radiation Sensitivity12
Knowledge-Based Planning for Intact Cervical Cancer12
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC10
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity10
Theranostics: The Role of Quantitative Nuclear Medicine Imaging10
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer9
Novel Agents and Future Perspectives on Theranostics9
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets9
Imaging and its Impact on Defining the Oligometastatic State9
The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade8
The Biological Process of Aging and the Impact of Ionizing Radiation8
Uncertainty Assessment for Deep Learning Radiotherapy Applications8
Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer8
Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date8
DCIS: Risk Assessment in the Molecular Era8
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer7
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations7
Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer7
The Spectrum of Metastasis: An Opportunity for Cure?7
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence6
Radiopharmaceuticals for Bone Metastases6
Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology6
Artificial Intelligence for Image Registration in Radiation Oncology6
Artificial Intelligence for Outcome Modeling in Radiotherapy6
Balancing Fractionation and Advanced Technology in Consideration of Reirradiation6
Incorporating Magnetic Resonance Imaging (MRI) Based Radiation Therapy Response Prediction into Clinical Practice for Locally Advanced Cervical Cancer Patients6
Aiming for 100% Local Control in Locally Advanced Cervical Cancer: The Role of Complex Brachytherapy Applicators and Intraprocedural Imaging6
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC6
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape6
The Medical Physics Management of Reirradiation Patients6
Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer6
0.023464918136597